Format

Send to

Choose Destination
Paediatr Drugs. 2017 Aug;19(4):313-324. doi: 10.1007/s40272-017-0231-7.

Immunization During Pregnancy: Impact on the Infant.

Author information

1
Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia. Kirsten.perrett@mcri.edu.au.
2
Melbourne Children's Trial Centre, Murdoch Childrens Research Institute, Melbourne, VIC, Australia. Kirsten.perrett@mcri.edu.au.
3
Department of General Medicine, Royal Children's Hospital, Melbourne, VIC, Australia. Kirsten.perrett@mcri.edu.au.
4
Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.

Abstract

Maternal immunization has undergone a paradigm shift in recent years, as women and healthcare providers accept and recognize the benefits of this strategy not only for the pregnant woman but also for the developing fetus and young infant. This article reviews the evidence for active immunization during pregnancy, with an emphasis on perinatal and infant outcomes. Current recommendations for immunization during pregnancy are presented, with particular focus on the routinely recommended vaccines during pregnancy: influenza and Tdap (tetanus, diphtheria, and pertussis). We discuss future research directions, maternal vaccines in development, and considerations for optimizing and advancing this underutilized strategy.

PMID:
28510067
DOI:
10.1007/s40272-017-0231-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center